Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 2/2011

01-10-2011 | Review

Monitoring and Detection of Vasospasm II: EEG and Invasive Monitoring

Authors: Daniel Hänggi, The Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage

Published in: Neurocritical Care | Issue 2/2011

Login to get access

Abstract

Several non-invasive and invasive modalities have been used to monitor patients for cerebral ischemia after subarachnoid hemorrhage. A literature search was performed to identify original research studies testing monitors that may be used in addition to the standard measures of brain function and cerebral blood flow. Fifty observational studies were identified that evaluated the role of electroencephalography, brain tissue oxygenation monitoring, cerebral microdialysis, thermal diffusion flowmetry, or near-infrared spectroscopy in patients after subarachnoid hemorrhage.
Literature
1.
Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res. 2004;4:38.PubMedCrossRef
2.
Claassen J, Hirsch LJ, Frontera JA, et al. Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care. 2006;4:103–12.PubMedCrossRef
3.
Claassen J, Hirsch LJ, Kreiter KT, et al. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol. 2004;115:2699–710.PubMedCrossRef
4.
Labar DR, Fisch BJ, Pedley TA, Fink ME, Solomon RA. Quantitative EEG monitoring for patients with subarachnoid hemorrhage. Electroencephalogr Clin Neurophysiol. 1991;78:325–32.PubMedCrossRef
5.
Rivierez M, Landau-Ferey J, Grob R, Grosskopf D, Philippon J. Value of electroencephalogram in prediction and diagnosis of vasospasm after intracranial aneurysm rupture. Acta Neurochir. 1991;110(Wien):17–23.CrossRef
6.
Stuart RM, Waziri A, Weintraub D, et al. Intracortical EEG for the detection of vasospasm in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care. 2010;13:355–8.PubMedCrossRef
7.
Vespa PM, Nuwer MR, Juhasz C, et al. Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring. Electroencephalogr Clin Neurophysiol. 1997;103:607–15.PubMedCrossRef
8.
Maloney-Wilensky E, Le Roux P. The physiology behind direct brain oxygen monitors and practical aspects of their use. Childs Nerv Syst. 2010;26:419–30.PubMedCrossRef
9.
Charbel FT, Du X, Hoffman WE, Ausman JI. Brain tissue PO(2), PCO(2), and pH during cerebral vasospasm. Surg Neurol. 2000;54:432–7. discussion 8.PubMedCrossRef
10.
Khaldi A, Zauner A, Reinert M, Woodward JJ, Bullock MR. Measurement of nitric oxide and brain tissue oxygen tension in patients after severe subarachnoid hemorrhage. Neurosurgery. 2001;49:33–8. discussion 8–40.PubMed
11.
Vath A, Kunze E, Roosen K, Meixensberger J. Therapeutic aspects of brain tissue pO2 monitoring after subarachnoid hemorrhage. Acta Neurochir. 2002;81(Suppl):307–9.
12.
Carvi y Nievas M, Toktamis S, Hollerhage HG, Haas E. Hyperacute measurement of brain-tissue oxygen, carbon dioxide, pH, and intracranial pressure before, during, and after cerebral angiography in patients with aneurysmatic subarachnoid hemorrhage in poor condition. Surg Neurol. 2005;64:362–7. discussion 7.PubMedCrossRef
13.
Meixensberger J, Vath A, Jaeger M, Kunze E, Dings J, Roosen K. Monitoring of brain tissue oxygenation following severe subarachnoid hemorrhage. Neurol Res. 2003;25:445–50.PubMedCrossRef
14.
Jaeger M, Soehle M, Schuhmann MU, Winkler D, Meixensberger J. Correlation of continuously monitored regional cerebral blood flow and brain tissue oxygen. Acta Neurochir. 2005;147(Wien):51–6. discussion 6.CrossRef
15.
Jaeger M, Schuhmann MU, Soehle M, Nagel C, Meixensberger J. Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction. Stroke. 2007;38:981–6.PubMedCrossRef
16.
Ramakrishna R, Stiefel M, Udoetuk J, et al. Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008;109:1075–82.PubMedCrossRef
17.
Barth M, Woitzik J, Weiss C, et al. Correlation of clinical outcome with pressure-, oxygen-, and flow-related indices of cerebrovascular reactivity in patients following aneurysmal SAH. Neurocrit Care. 2010;12:234–43.PubMedCrossRef
18.
Oddo M, Milby A, Chen I, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:1275–81.PubMedCrossRef
19.
Persson L, Hillered L. Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg. 1992;76:72–80.PubMedCrossRef
20.
Hamberger A, Runnerstam M, Nystrom B, Starmark JE, von Essen C. The neuronal environment after subarachnoid haemorrhage–correlation of amino acid and nucleoside levels with post-operative recovery. Neurol Res. 1995;17:97–105.PubMed
21.
Persson L, Valtysson J, Enblad P, et al. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg. 1996;84:606–16.PubMedCrossRef
22.
Enblad P, Valtysson J, Andersson J, et al. Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1996;16:637–44.PubMedCrossRef
23.
Runnerstam M, von Essen C, Nystrom B, Rosengren L, Hamberger A. Extracellular glial fibrillary acidic protein and amino acids in brain regions of patients with subarachnoid hemorrhage–correlation with level of consciousness and site of bleeding. Neurol Res. 1997;19:361–8.PubMed
24.
Saveland H, Nilsson OG, Boris-Moller F, Wieloch T, Brandt L. Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1996;38:12–9. discussion 9–20.PubMedCrossRef
25.
Shuaib A, Kanthan R, Goplen G, et al. In vivo microdialysis study of extracellular glutamate response to temperature variance in subarachnoid hemorrhage. Acta Neurochir. 1996;67(Suppl):53–8.
26.
Hillered L, Valtysson J, Enblad P, Persson L. Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry. 1998;64:486–91.PubMedCrossRef
27.
Nilsson OG, Brandt L, Ungerstedt U, Saveland H. Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery. 1999;45:1176–84. discussion 84–5.PubMedCrossRef
28.
Schulz MK, Wang LP, Tange M, Bjerre P. Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;93:808–14.PubMedCrossRef
29.
Sarrafzadeh A, Haux D, Plotkin M, Ludemann L, Amthauer H, Unterberg A. Bedside microdialysis reflects dysfunction of cerebral energy metabolism in patients with aneurysmal subarachnoid hemorrhage as confirmed by 15 O-H2 O-PET and 18 F-FDG-PET. J Neuroradiol. 2005;32:348–51.PubMedCrossRef
30.
Sarrafzadeh AS, Thomale UW, Haux D, Unterberg AW. Cerebral metabolism and intracranial hypertension in high grade aneurysmal subarachnoid haemorrhage patients. Acta Neurochir. 2005;95(Suppl):89–92.CrossRef
31.
Hanafy KA, Grobelny B, Fernandez L, et al. Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage. J Neurol Sci. 2010;291:69–73.PubMedCrossRef
32.
Mellergard P, Sjogren F, Hillman J. Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans. Br J Neurosurg. 2010;24:261–7.PubMedCrossRef
33.
Helbok R, Schmidt JM, Kurtz P, et al. Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care. 2010;12:317–23.PubMedCrossRef
34.
Zetterling M, Hallberg L, Hillered L, Karlsson T, Enblad P, Ronne Engstrom E. Brain energy metabolism in patients with spontaneous subarachnoid hemorrhage and global cerebral edema. Neurosurgery. 2010;66:1102–10.PubMedCrossRef
35.
Staub F, Graf R, Gabel P, Kochling M, Klug N, Heiss WD. Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage. Neurosurgery. 2000;47:1106–15. discussion 15–6.PubMedCrossRef
36.
Sarrafzadeh AS, Haux D, Ludemann L, et al. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke. 2004;35:638–43.PubMedCrossRef
37.
Skjoth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P. Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;100:8–15.PubMedCrossRef
38.
Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, Unterberg AW. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med. 2002;30:1062–70.PubMedCrossRef
39.
Sarrafzadeh A, Haux D, Sakowitz O, et al. Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke. 2003;34:1382–8.PubMedCrossRef
40.
Sakowitz OW, Wolfrum S, Sarrafzadeh AS, et al. Relation of cerebral energy metabolism and extracellular nitrite and nitrate concentrations in patients after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2001;21:1067–76.PubMedCrossRef
41.
Kastner S, Oertel MF, Scharbrodt W, Krause M, Boker DK, Deinsberger W. Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH. Acta Neurochir. 2005;147(Wien):1271–9. discussion 9.CrossRef
42.
Maurer MH, Haux D, Sakowitz OW, Unterberg AW, Kuschinsky W. Identification of early markers for symptomatic vasospasm in human cerebral microdialysate after subarachnoid hemorrhage: preliminary results of a proteome-wide screening. J Cereb Blood Flow Metab. 2007;27:1675–83.PubMedCrossRef
43.
Schlenk F, Frieler K, Nagel A, Vajkoczy P, Sarrafzadeh AS. Cerebral microdialysis for detection of bacterial meningitis in aneurysmal subarachnoid hemorrhage patients: a cohort study. Crit Care. 2009;13:R2.PubMedCrossRef
44.
Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2001;94:740–9.PubMedCrossRef
45.
Samuelsson C, Howells T, Kumlien E, Enblad P, Hillered L, Ronne-Engstrom E. Relationship between intracranial hemodynamics and microdialysis markers of energy metabolism and glutamate-glutamine turnover in patients with subarachnoid hemorrhage. Clinical article. J Neurosurg. 2009;111:910–5.PubMedCrossRef
46.
Sarrafzadeh AS, Nagel A, Czabanka M, Denecke T, Vajkoczy P, Plotkin M. Imaging of hypoxic-ischemic penumbra with (18)F-fluoromisonidazole PET/CT and measurement of related cerebral metabolism in aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2010;30:36–45.PubMedCrossRef
47.
Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003;98:1227–34.PubMedCrossRef
48.
Barth M, Capelle HH, Munch E, et al. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage—preliminary results from a randomized clinical series. Acta Neurochir. 2007;149(Wien):911–8. discussion 8.CrossRef
49.
Keller E, Nadler A, Imhof HG, Niederer P, Roth P, Yonekawa Y. New methods for monitoring cerebral oxygenation and hemodynamics in patients with subarachnoid hemorrhage. Acta Neurochir. 2002;82(Suppl):87–92.
50.
Brawanski A, Faltermeier R, Rothoerl RD, Woertgen C. Comparison of near-infrared spectroscopy and tissue p(O2) time series in patients after severe head injury and aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2002;22:605–11.PubMedCrossRef
51.
Zweifel C, Castellani G, Czosnyka M, et al. Continuous assessment of cerebral autoregulation with near-infrared spectroscopy in adults after subarachnoid hemorrhage. Stroke. 2010;41:1963–8.PubMedCrossRef
52.
Mutoh T, Ishikawa T, Suzuki A, Yasui N. Continuous cardiac output and near-infrared spectroscopy monitoring to assist in management of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2010;13:331–8.PubMedCrossRef
53.
Yokose N, Sakatani K, Murata Y, et al. Bedside assessment of cerebral vasospasms after subarachnoid hemorrhage by near infrared time-resolved spectroscopy. Adv Exp Med Biol. 2010;662:505–11.PubMedCrossRef
54.
Naidech AM, Bendok BR, Ault ML, Bleck TP. Monitoring with the Somanetics INVOS 5100C after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;9:326–31.PubMedCrossRef
Metadata
Title
Monitoring and Detection of Vasospasm II: EEG and Invasive Monitoring
Authors
Daniel Hänggi
The Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage
Publication date
01-10-2011
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 2/2011
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-011-9583-y

Other articles of this Issue 2/2011

Neurocritical Care 2/2011 Go to the issue

Review

Monitoring of Volume Status After Subarachnoid Hemorrhage

Review

Vasospasm Versus Delayed Cerebral Ischemia as an Outcome Event in Clinical Trials and Observational Studies

Review

Spontaneous Subarachnoid Hemorrhage and Glucose Management

Review

Magnesium Sulfate Administration in Subarachnoid Hemorrhage

Review

High-Volume Centers

Review

SAH Pituitary Adrenal Dysfunction